(Q84807162)

English

Hepatic Intra-Arterial Injection of Drug-Eluting Bead, Irinotecan (DEBIRI) in Unresectable Colorectal Liver Metastases Refractory to Systemic Chemotherapy: Results of Multi-Institutional Study

scientific article published on August 26, 2010

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20740319%20AND%20SRC:MED&resulttype=core&format=json

11 February 2020

Hepatic intra-arterial injection of drug-eluting bead, irinotecan (DEBIRI) in unresectable colorectal liver metastases refractory to systemic chemotherapy: results of multi-institutional study (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20740319%20AND%20SRC:MED&resulttype=core&format=json

11 February 2020

Hepatic Intra-Arterial Injection of Drug-Eluting Bead, Irinotecan (DEBIRI) in Unresectable Colorectal Liver Metastases Refractory to Systemic Chemotherapy: Results of Multi-Institutional Study (English)

1 reference

10.1245/S10434-010-1288-5

https://api.crossref.org/works/10.1245/S10434-010-1288-5

23 June 2024

1 reference

based on heuristic

inferred from title

Robert C G Martin

1

object named as

Robert C G Martin

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20740319%20AND%20SRC:MED&resulttype=core&format=json

11 February 2020

author name string

Jonathan Joshi

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20740319%20AND%20SRC:MED&resulttype=core&format=json

11 February 2020

Ken Robbins

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20740319%20AND%20SRC:MED&resulttype=core&format=json

11 February 2020

Dana Tomalty

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20740319%20AND%20SRC:MED&resulttype=core&format=json

11 February 2020

Petar Bosnjakovik

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20740319%20AND%20SRC:MED&resulttype=core&format=json

11 February 2020

Milous Derner

6

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20740319%20AND%20SRC:MED&resulttype=core&format=json

11 February 2020

Radek Padr

7

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20740319%20AND%20SRC:MED&resulttype=core&format=json

11 February 2020

Miloslav Rocek

8

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20740319%20AND%20SRC:MED&resulttype=core&format=json

11 February 2020

Alexander Scupchenko

9

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20740319%20AND%20SRC:MED&resulttype=core&format=json

11 February 2020

Cliff Tatum

10

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20740319%20AND%20SRC:MED&resulttype=core&format=json

11 February 2020

language of work or name

1 reference

National Center for Biotechnology Information

PubMed publication ID

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=20740319

23 June 2024

publication date

26 August 2010

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20740319%20AND%20SRC:MED&resulttype=core&format=json

11 February 2020

full work available at URL

http://www.annalssurgicaloncology.org/cgi/content/abstract/18/1/192

online access status

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A20740319

23 June 2024

http://link.springer.com/content/pdf/10.1245/s10434-010-1288-5.pdf

Portable Document Format

1 reference

10.1245/S10434-010-1288-5

https://api.crossref.org/works/10.1245/S10434-010-1288-5

23 June 2024

http://link.springer.com/article/10.1245/s10434-010-1288-5/fulltext.html

1 reference

10.1245/S10434-010-1288-5

https://api.crossref.org/works/10.1245/S10434-010-1288-5

23 June 2024

http://link.springer.com/content/pdf/10.1245/s10434-010-1288-5

1 reference

10.1245/S10434-010-1288-5

https://api.crossref.org/works/10.1245/S10434-010-1288-5

23 June 2024

Annals of Surgical Oncology

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20740319%20AND%20SRC:MED&resulttype=core&format=json

11 February 2020

18

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20740319%20AND%20SRC:MED&resulttype=core&format=json

11 February 2020

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20740319%20AND%20SRC:MED&resulttype=core&format=json

11 February 2020

192-198

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20740319%20AND%20SRC:MED&resulttype=core&format=json

11 February 2020

https://scigraph.springernature.com/pub.10.1245/s10434-010-1288-5

0 references

Phase II multicenter trial of bevacizumab plus fluorouracil and leucovorin in patients with advanced refractory colorectal cancer: an NCI Treatment Referral Center Trial TRC-0301.

1

1 reference

10.1245/S10434-010-1288-5

https://api.crossref.org/works/10.1245/S10434-010-1288-5

23 June 2024

Randomized phase II trial of cetuximab, bevacizumab, and irinotecan compared with cetuximab and bevacizumab alone in irinotecan-refractory colorectal cancer: the BOND-2 study

2

1 reference

10.1245/S10434-010-1288-5

https://api.crossref.org/works/10.1245/S10434-010-1288-5

23 June 2024

Quality of life and survival with continuous hepatic-artery floxuridine infusion for colorectal liver metastases.

3

1 reference

10.1245/S10434-010-1288-5

https://api.crossref.org/works/10.1245/S10434-010-1288-5

23 June 2024

A randomized trial of continuous intravenous versus hepatic intraarterial floxuridine in patients with colorectal cancer metastatic to the liver: the Northern California Oncology Group trial

4

1 reference

10.1245/S10434-010-1288-5

https://api.crossref.org/works/10.1245/S10434-010-1288-5

23 June 2024

Recommendations for radioembolization of hepatic malignancies using yttrium-90 microsphere brachytherapy: a consensus panel report from the radioembolization brachytherapy oncology consortium.

5

1 reference

10.1245/S10434-010-1288-5

https://api.crossref.org/works/10.1245/S10434-010-1288-5

23 June 2024

Radioembolization of liver metastases from colorectal cancer using yttrium-90 microspheres with concomitant systemic oxaliplatin, fluorouracil, and leucovorin chemotherapy.

6

1 reference

10.1245/S10434-010-1288-5

https://api.crossref.org/works/10.1245/S10434-010-1288-5

23 June 2024

Morbidity of adjuvant hepatic arterial infusion pump chemotherapy in the management of colorectal cancer metastatic to the liver

7

1 reference

10.1245/S10434-010-1288-5

https://api.crossref.org/works/10.1245/S10434-010-1288-5

23 June 2024

Transarterial Chemoembolization of Metastatic Colorectal Carcinoma with Drug-Eluting Beads, Irinotecan (DEBIRI): Multi-Institutional Registry

8

1 reference

10.1245/S10434-010-1288-5

https://api.crossref.org/works/10.1245/S10434-010-1288-5

23 June 2024

Transarterial chemoembolisation (TACE) using irinotecan-loaded beads for the treatment of unresectable metastases to the liver in patients with colorectal cancer: an interim report

9

1 reference

10.1245/S10434-010-1288-5

https://api.crossref.org/works/10.1245/S10434-010-1288-5

23 June 2024

Registries that show efficacy: good, but not good enough

10

1 reference

10.1245/S10434-010-1288-5

https://api.crossref.org/works/10.1245/S10434-010-1288-5

23 June 2024

Correlation of computed tomography and positron emission tomography in patients with metastatic gastrointestinal stromal tumor treated at a single institution with imatinib mesylate: proposal of new computed tomography response criteria.

11

1 reference

10.1245/S10434-010-1288-5

https://api.crossref.org/works/10.1245/S10434-010-1288-5

23 June 2024

Design and endpoints of clinical trials in hepatocellular carcinoma.

12

1 reference

10.1245/S10434-010-1288-5

https://api.crossref.org/works/10.1245/S10434-010-1288-5

23 June 2024

New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1)

13

1 reference

10.1245/S10434-010-1288-5

https://api.crossref.org/works/10.1245/S10434-010-1288-5

23 June 2024

Cetuximab monotherapy and cetuximab plus irinotecan in irinotecan-refractory metastatic colorectal cancer

14

1 reference

10.1245/S10434-010-1288-5

https://api.crossref.org/works/10.1245/S10434-010-1288-5

23 June 2024

A randomized controlled trial of fluorouracil plus leucovorin, irinotecan, and oxaliplatin combinations in patients with previously untreated metastatic colorectal cancer.

15

1 reference

10.1245/S10434-010-1288-5

https://api.crossref.org/works/10.1245/S10434-010-1288-5

23 June 2024

Phase III study of weekly high-dose infusional fluorouracil plus folinic acid with or without irinotecan in patients with metastatic colorectal cancer: European Organisation for Research and Treatment of Cancer Gastrointestinal Group Study 40986.

16

1 reference

10.1245/S10434-010-1288-5

https://api.crossref.org/works/10.1245/S10434-010-1288-5

23 June 2024

Phase III randomized trial of FOLFIRI versus FOLFOX4 in the treatment of advanced colorectal cancer: a multicenter study of the Gruppo Oncologico Dell'Italia Meridionale

17

1 reference

10.1245/S10434-010-1288-5

https://api.crossref.org/works/10.1245/S10434-010-1288-5

23 June 2024

FOLFIRI followed by FOLFOX6 or the reverse sequence in advanced colorectal cancer: a randomized GERCOR study

18

1 reference

10.1245/S10434-010-1288-5

https://api.crossref.org/works/10.1245/S10434-010-1288-5

23 June 2024

Oxaliplatin with high-dose leucovorin and 5-fluorouracil 48-hour continuous infusion in pretreated metastatic colorectal cancer

19

1 reference

10.1245/S10434-010-1288-5

https://api.crossref.org/works/10.1245/S10434-010-1288-5

23 June 2024

Superiority of oxaliplatin and fluorouracil-leucovorin compared with either therapy alone in patients with progressive colorectal cancer after irinotecan and fluorouracil-leucovorin: interim results of a phase III trial

20

1 reference

10.1245/S10434-010-1288-5

https://api.crossref.org/works/10.1245/S10434-010-1288-5

23 June 2024

Multicenter phase II trial of dose-fractionated irinotecan in patients with advanced colorectal cancer failing oxaliplatin-based first-line combination chemotherapy

21

1 reference

10.1245/S10434-010-1288-5

https://api.crossref.org/works/10.1245/S10434-010-1288-5

23 June 2024

Oxaliplatin, folinic acid and 5-fluorouracil (FOLFOX-4) combination chemotherapy as second-line treatment in advanced colorectal cancer patients with irinotecan failure: a Korean single-center experience.

22

1 reference

10.1245/S10434-010-1288-5

https://api.crossref.org/works/10.1245/S10434-010-1288-5

23 June 2024

Hepatic arterial infusion of oxaliplatin and intravenous LV5FU2 in unresectable liver metastases from colorectal cancer after systemic chemotherapy failure

23

1 reference

10.1245/S10434-010-1288-5

https://api.crossref.org/works/10.1245/S10434-010-1288-5

23 June 2024

Adjuvant hepatic arterial chemotherapy following metastasectomy in patients with isolated liver metastases

24

1 reference

10.1245/S10434-010-1288-5

https://api.crossref.org/works/10.1245/S10434-010-1288-5

23 June 2024

Surgical downstaging and neo-adjuvant therapy in metastatic colorectal carcinoma with irinotecan drug-eluting beads: a multi-institutional study

26

1 reference

10.1245/S10434-010-1288-5

https://api.crossref.org/works/10.1245/S10434-010-1288-5

23 June 2024

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q84807162&oldid=2187191221"